HLA-C expression pattern is spatially different between psoriasis and eczema skin lesions

Journal of Investigative Dermatology

Volumn 127, Issue 2, 2007, Pages 342-348

  Carlén, Lina ^a   Sakuraba, Kazuko ^a   Ståhle, Mona ^a   Sánchez, Fabio ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A1 ANTIGEN; HLA C ANTIGEN; PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; BASAL CELL; BASEMENT MEMBRANE; CONTACT DERMATITIS; DERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; INFLAMMATORY CELL; POLARIZATION; PRIORITY JOURNAL; PSORIASIS; SAMPLE; SKIN; SKIN EPITHELIUM;

BLOTTING, WESTERN; CELL LINE; COLON; DERMATITIS, ALLERGIC CONTACT; ECZEMA; ESCHERICHIA COLI; FETUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-C ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; PSORIASIS; SKIN; STAINING AND LABELING; TISSUE DISTRIBUTION; TONSIL; TRANSFECTION;

EID: 33846185524     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700549     Document Type: Article

References (59)

1. Baba E, Erskine R, Boyson JE, Cohen GB, Davis DM, Malik P et al. (2000) N-linked carbohydrate on human leukocyte antigen-C and recognition by natural killer cell inhibitory receptors. Hum Immunol 61: 1202-18
2. Balendran N, Clough RL, Arguello JR, Barber R, Veal C, Jones AB et al. (1999) Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3. J Invest Dermatol 113:322-8
3. Bowcock AM (2005) The genetics of psoriasis and autoimmunity. Annu Rev Genomics Hum Genet 6:93-122
4. Bowcock AM, Krueger JG (2005) Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 5:699-711
5. Boyington JC, Brooks AG, Sun PD (2001) Structure of killer cell immunoglobulin-like receptors and their recognition of the class I MHC molecules. Immunol Rev 181:66-78
6. Boyington JC, Sun PD (2002) A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Mol Immunol 38:1007-21
7. Boyton RJ, Smith J, Ward R, Jones M, Ozerovitch L, Wilson R et al. (2006) HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. Am J Respir Crit Care Med 173:327-33
8. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-54
9. Brodsky FM, Parham P, Barnstable CJ, Crumpton MJ, Bodmer WF (1979) Monoclonal antibodies for analysis of the HLA system. Immunol Rev 47:3-61
10. Capon F, Allen MH, Ameen M, Burden AD, Tillman D, Barker JN et al. (2004) A synonymous SNP of the corneodesmosin gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups. Hum Mol Genet 13:2361-8
11. Carlen LM, Sanchez F, Bergman AC, Becker S, Hirschberg D, Franzen B et al. (2005) Proteome analysis of skin distinguishes acute guttate from chronic plaque psoriasis. J Invest Dermatol 124:63-9
12. Carlin LM, Eleme K, McCann FE, Davis DM (2001) Intercellular transfer and supramolecular organization of human leukocyte antigen C at inhibitory natural killer cell immune synapses. J Exp Med 194:1507-17
13. Carosella ED, Moreau P, Aractingi S, Rouas-Freiss N (2001) HLA-G: a shield against inflammatory aggression. Trends Immunol 22:553-5
14. Davison SC, Ballsdon A, Allen MH, Barker JN (2001) Early migration of cutaneous lymphocyte-associated antigen (CLA) positive T cells into evolving psoriatic plaques. Exp Dermatol 10:280-5
15. Garcia-Lora A, Algarra I, Collado A, Garrido F (2003) Tumour immunology, vaccination and escape strategies. Eur J Immunogenet 30: 177-83
16. Gewurz BE, Gaudet R, Tortorella D, Wang EW, Ploegh HL (2001) Virus subversion of immunity: a structural perspective. Curr Opin Immunol 13:442-50
17. Gross WL, Packhauser U, Hahn G, Westphal E, Christophers E, Schlaak M (1977) Lymphocyte activation by streptococcal antigens in psoriasis. Br J Dermatol 97:529-36
18. Gross WL, Vorwerk I, Westphal E, Christophers E, Hahn G, Schlaak M (1983) HLA-related lymphocyte responsiveness in psoriasis. Int Arch Allergy Appl Immunol 70:151-6
19. Helms C, Saccone NL, Cao L, Daw JA, Cao K, Hsu TM et al. (2005) Localization of PSORS1 to a haplotype block harboring HLA-C and distinct from corneodesmosin and HCR. Hum Genet 118: 466-76
20. Henseler T, Christophers E (1985) Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13:450-6
21. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CW, Carrington M, Trowsdale J et al. (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200:957-65
22. Holm SJ, Carlen LM, Mallbris L, Stahle-Backdahl M, O'Brien KP (2003) Polymorphisms in the SEEK1 and SPR1 genes on 6p21.3 associate with psoriasis in the Swedish population. Exp Dermatol 12:435-44
23. Holm SJ, Sakuraba K, Mallbris L, Wolk K, Stahle M, Sanchez FO (2005) Distinct HLA-C/KIR genotype profile associates with guttate psoriasis. J Invest Dermatol 125:721-30
24. Ihaka R, Gentleman R (1996) A language for data analysis and graphics. J Comput Graph Statist 5:299-314
25. Jenisch S, Henseler T, Nair RP, Guo SW, Westphal E, Stuart P et al. (1998) Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am J Hum Genet 63: 191-9
26. Johnston A, Gudjonsson JE, Sigmundsdottir H, Love TJ, Valdimarsson H (2004) Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8(+) T cells. Clin Exp Immunol 138:83-93
27. Kaneko F, Itoh N, Yoshida H, Suzuki M, Ono I (1991) The cell-components and cytokines in the subcorneal microabscess of psoriasis. Fukushima J Med Sci 37:103-12
28. Krueger JG, Bowcock A (2005) Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 64(Suppl 2):ii30-6
29. Langley RG, Krueger GG, Griffiths CE (2005) Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 64(Suppl 2):ii18-23 (discussion ii24-ii25)
30. Laurentaci G, Lomuto M, Favoino B (1982) Immunogenetic analysis of association between HLA antigens and psoriasis vulgaris: population and family studies. Dermatologica 165:591-600
31. Lebedeva T, Anikeeva N, Kalams SA, Walker BD, Gaidarov I, Keen JH et al. (2004) Major histocompatibility complex class I-intercellular adhesion molecule-1 association on the surface of target cells: implications for antigen presentation to cytotoxic T lymphocytes. Immunology 113:460-71
32. Le Bouteiller P (2001) [HLA molecules, immunity and gestation]. Gynecol Obstet Fertil 29:523-31
33. Le Discorde M, Moreau P, Rouas-Freiss N, Carosella E (2002) [HLA-G: immune tolerance in normal and pathological physiology]. Pathol Biol (Paris) 50:45-51
34. Lin WJ, Norris DA, Achziger M, Kotzin BL, Tomkinson B (2001) Oligoclonal expansion of intraepidermal T cells in psoriasis skin lesions. J Invest Dermatol 117:1546-53
35. Luszczek W, Manczak M, Cislo M, Nockowski P, Wisniewski A, Jasek M et al. (2004) Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. Hum Immunol 65:758-66
36. Mallon E, Bunce M, Savoie H, Rowe A, Newson R, Gotch F et al. (2000) HLA-C and guttate psoriasis. Br J Dermatol 143:1177-82
37. Martin MP, Carrington M (2005) Immunogenetics of viral infections. Curr Opin Immunol 17:510-6
38. Martin MP, Nelson G, Lee JH, Pellett F, Gao X, Wade J et al. (2002) Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 169:2818-22
39. McCutcheon J, Gumperz J, Smith K, Lutz C, Parham P (1995) Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J Exp Med 181:2085-95
40. McMichael AJ, Morhenn V, Payne R, Sasazuki T, Farber EM (1978) HLA C and D antigens associated with psoriasis. Br J Dermatol 98:287-92
41. Moretta L, Moretta A (2004) Killer immunoglobulin-like receptors. Curr Opin Immunol 16:626-33
42. Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E et al. (2000) Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet 66:1833-44
43. Neisig A, Melief CJM, Neefjes J (1998) Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J Immunol 160:171-9
44. Nickoloff BJ, Schroder JM, von den Driesch P, Raychaudhuri SP, Farber EM, Boehncke WH et al. (2000) Is psoriasis a T-cell disease? Exp Dermatol 9:359-75
45. Nyulassy S, Hnilica P, Buc M, Guman M, Hirschova V, Stefanovic J (1977) Subacute (de Quervain's) thyroiditis: association with HLA-Bw35 antigen and abnormalities of the complement system, immunoglobulins and other serum proteins. J Clin Endocrinol Metab 45:270-4
46. Oka A, Tamiya G, Tomizawa M, Ota M, Katsuyama Y, Makino S et al. (1999) Association analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111 kb segment telomeric to the HLA-C gene. Hum Mol Genet 8:2165-70
47. Parham P (2004) NK cells and trophoblasts: partners in pregnancy. J Exp Med 200:951-5
48. Petersdorf EW, Longton GM, Anasetti C, Mickelson EM, McKinney SK, Smith AG et al. (1997) Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 89:1818-23
49. Puppo F, Contini P, Ghio M, Indiveri F (2002) Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction. Sci World J 2:421-3
50. Rajagopalan S, Long EO (2005) Understanding how combinations of HLA and KIR genes influence disease. J Exp Med 201:1025-9
51. Rubin LA, Amos CI, Wade JA, Martin JR, Bale SJ, Little AH et al. (1994) Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region. Arthritis Rheum 37:1212-20
52. Setini A, Beretta A, De Santis C, Meneveri R, Martayan A, Mazzilli MC et al. (1996) Distinctive features of the alpha 1-domain alpha helix of HLA-C heavy chains free of beta 2-microglobulin. Hum Immunol 46:69-81
53. Spaggiari GM, Contini P, Dondero A, Carosio R, Puppo F, Indiveri F et al. (2002) Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction. Blood 100:4098-107
54. Suomela S, Elomaa O, Asumalahti K, Kariniemi AL, Karvonen SL, Peltonen J et al. (2003) HCR, a candidate gene for psoriasis, is expressed differently in psoriasis and other hyperproliferative skin disorders and is down-regulated by interferon-gamma in keratinocytes. J Invest Dermatol 121:1360-4
55. Trowsdale J, Betz AG (2006) Mother's little helpers: mechanisms of maternalfetal tolerance. Nat Immunol 7:241-6
56. Winter C, Long E (1997) A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J Immunol 158:4026-8
57. Wolf R, Ruocco V (1999) Triggered psoriasis. Adv Exp Med Biol 455:221-5
58. Zhou X, Krueger JG, Kao MC, Lee E, Du F, Menter A et al. (2003) Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics 13:69-78
59. Zimmer J, Andres E, Donato L, Hanau D, Hentges F, de la Salle H (2005) Clinical and immunological aspects of HLA class I deficiency. QJM 98:719-27